デフォルト表紙
市場調査レポート
商品コード
1362999

バイオテクノロジー機器の市場規模、シェア、動向分析レポート:製品別、最終用途別、セグメント予測、2023年~2030年

Biotechnology Instruments Market Size, Share & Trends Analysis Report By Product (Cell Culture Instruments, Analytical Instruments), By End-use (Pharma & Biotech Companies, Academic & Research Institutes), And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 180 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
バイオテクノロジー機器の市場規模、シェア、動向分析レポート:製品別、最終用途別、セグメント予測、2023年~2030年
出版日: 2023年09月13日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオテクノロジー機器市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のバイオテクノロジー機器市場規模は2030年までに1,166億8,000万米ドルに達し、2023年から2030年までのCAGRは3.94%を示す見込みです。

ライフサイエンス研究技術の進歩、個別化された医薬品・診断検査に対する需要の高まり、がんなどの疾患に対する医薬品・ワクチン開発の研究開発の高まりが、市場成長を後押ししています。POC診断の需要は、在院日数を短縮するための外来診療モデルの確立に向けた政府の取り組みの増加や、高齢者人口のニーズに対応するための在宅・医療環境におけるPOC機器のニーズの高まりなどの要因によって牽引されると予測されます。

さらに、バイオテクノロジー産業の拡大は、新製品・革新的製品のイントロダクション、契約、買収、技術進歩、さまざまな用途での採用拡大など、さまざまな要因に関連しています。2023年5月、インドの新興企業NeoDx Biotech Labsは、C型肝炎、B型肝炎、HIVなどの感染症を診断するリアルタイムPCRベースのキットを7種類発売し、様々な病院や診断センターで利用されるようになっています。同様に、2023年1月、Bio-Radは、FDAのIVD検査認可を受けたリアルタイムPCRシステムCFX Opus Deepwell Dxの発売を発表しました。このように、これらの技術的な発売は、期間中の市場成長を促進すると予測されています。さらに、企業はより優れた、より高度なシーケンス技術を促進する新製品を発売しています。

例えば、2023年4月、Biomodal社(旧Cambridge Epigenetix社)は、duetマルチオミクスソリューションの発売を発表しました。この新しいマルチオミクスシーケンス技術は、単一の少量サンプルから抽出される遺伝学的およびエピジェネティックな洞察の相乗的な可能性を強調すると予測されています。さらに、このソリューションは、単一サンプルから遺伝学的詳細とエピジェネティック詳細の両方を同時に段階的に読み取ることを可能にする、初の単一塩基分解能シーケンス技術の一つです。これにより、あらゆるシーケンシングプラットフォームと統合されたワークフローにおける同技術の応用が拡大します。シーケンシング技術における技術的進歩の採用の増加は、市場成長を促進すると予想されます。

バイオテクノロジー機器市場レポートハイライト

  • 製品別では、分析機器セグメントが2022年に61.92%のシェアで市場を独占しました。
  • 先進的な医薬品開発、バイオマーカー探索、医薬品の品質管理に対する需要の高まりが、予測期間中の同セグメントの成長を促進すると予測されます。
  • 最終用途別では、製薬・バイオテクノロジー企業が2022年に38.10%の最大市場シェアを占めました。
  • これは、がんなどの様々な疾患に対する薬物療法の増加、ワクチン開発、疾患のモニタリングと検出のための診断ツールの設計などに起因しています。
  • 2022年には、北米が43.95%のシェアで市場を独占したが、これは大手企業の存在と強固な医療インフラによる。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 変数、動向、範囲

  • 市場系統の見通し
  • 市場動向と展望
  • 市場力学
  • 市場抑制要因分析
  • 事業環境分析

第4章 製品のビジネス分析

  • バイオテクノロジー機器市場:製品の変動分析
  • 分析機器
    • ポリメラーゼ連鎖反応
    • 分光法
    • 顕微鏡検査
    • クロマトグラフィ
    • フローサイトメトリー
    • シーケンシング
    • マイクロアレイ
    • その他
  • 細胞培養機器
    • 培養システム
    • 保育器
    • 極低温保存装置
    • バイオセーフティ装置
    • ピペット器具
  • 細胞分離機器
    • 遠心
    • ろ過システム
    • 磁気活性化細胞分離システム
  • 免疫測定機器
  • 臨床化学分析装置
  • その他

第5章 最終用途のビジネス分析

  • バイオテクノロジー機器市場:最終用途の変動分析
  • 製薬・バイオテクノロジー企業
  • 病院・診断研究所
  • 学術・研究機関
  • その他

第6章 地域のビジネス分析

  • 地域の市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • タイ
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • Thermo Fisher Scientific, Inc.
    • Waters Corp.
    • Shimadzu Corp.
    • Danaher
    • Agilent Technologies, Inc.
    • Bruker Corp.
    • PerkinElmer, Inc.
    • Mettler Toledo
    • Zeiss Group
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • Eppendorf SE
    • F. Hoffmann-La Roche AG
    • Sartorius AG
    • Avantor, Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 Canada biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Europe biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 12 Europe biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 UK biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 14 UK biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 16 Germany biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 France biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 18 France biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Italy biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 20 Italy biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Spain biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 22 Spain biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Denmark biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 24 Denmark biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Sweden biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 26 Sweden biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 28 Norway biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 China biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 33 China biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Japan biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 35 Japan biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 India biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 37 India biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 South Korea biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 39 South Korea biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Australia biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 43 Thailand biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Latin America biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 45 Latin America biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 46 Latin America biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Brazil biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 48 Brazil biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Mexico biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 50 Mexico biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Argentina biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 52 Argentina biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa biotechnology instruments market, by country, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Africa biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Africa biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 UAE biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 61 UAE biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait biotechnology instruments market, by product, 2018 - 2030 (USD Million)
  • Table 63 Kuwait biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global biotechnology instruments market - Key market driver analysis
  • Fig. 7 Global biotechnology instruments market - Key market restraint analysis
  • Fig. 8 Global biotechnology instruments market - Porter's analysis
  • Fig. 9 Global biotechnology instruments market - PESTEL analysis
  • Fig. 10 Global biotechnology instruments market: Product outlook key takeaways
  • Fig. 11 Global biotechnology instruments market: Product movement analysis
  • Fig. 12 Analytical instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 13 Polymerase chain reaction market estimates, 2018 - 2030 (USD Million)
  • Fig. 14 Spectroscopy market estimates, 2018 - 2030 (USD Million)
  • Fig. 15 Microscopy market estimates, 2018 - 2030 (USD Million)
  • Fig. 16 Chromatography market estimates, 2018 - 2030 (USD Million)
  • Fig. 17 Flow cytometry market estimates, 2018 - 2030 (USD Million)
  • Fig. 18 Sequencing market estimates, 2018 - 2030 (USD Million)
  • Fig. 19 Microarray market estimates, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 21 Cell culture instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 22 Culture systems market estimates, 2018 - 2030 (USD Million)
  • Fig. 23 Incubators market estimates, 2018 - 2030 (USD Million)
  • Fig. 24 Cryostorage equipment market estimates, 2018 - 2030 (USD Million)
  • Fig. 25 Biosafety equipment market estimates, 2018 - 2030 (USD Million)
  • Fig. 26 Pipetting instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 27 Cell separation instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 28 Centrifuge market estimates, 2018 - 2030 (USD Million)
  • Fig. 29 Filtration systems market estimates, 2018 - 2030 (USD Million)
  • Fig. 30 Magnetic - activated cell separator systems market estimates, 2018 - 2030 (USD Million)
  • Fig. 31 Immnuoassay instruments market estimates, 2018 - 2030 (USD Million)
  • Fig. 32 Clinical chemistry analyzers market estimates, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 34 Global biotechnology instruments market: End - use outlook key takeaways
  • Fig. 35 Global biotechnology instruments market: End - use movement analysis
  • Fig. 36 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
  • Fig. 37 Hospitals & diagnostic laboratories market estimates, 2018 - 2030 (USD Million)
  • Fig. 38 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 40 Regional marketplace: Key takeaways
  • Fig. 41 Global biotechnology instruments market: Regional movement analysis
  • Fig. 42 North America biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 46 UK biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 48 France biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 53 Norway biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 55 Japan biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 56 China biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 57 India biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 65 MEA biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 68 UAE biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait biotechnology instruments market, 2018 - 2030 (USD Million)
  • Fig. 70 Strategy framework
目次
Product Code: GVR-4-68039-625-9

Biotechnology Instruments Market Growth & Trends:

The global biotechnology instruments market size is expected to reach USD 116.68 billion by 2030, according to a new report by Grand View Research, Inc.., exhibiting a CAGR of 3.94% from 2023 to 2030. The growing advancements in life science research technologies, growing demand for personalized medicines & diagnostics tests, and rising R&D for drug & vaccine developments for diseases, such as cancer, collectively propel the market growth. The demand for POC diagnostics is projected to be driven by factors, such as increasing government initiatives to establish outpatient care models for shortening hospital stays and the rising need for POC devices in home & healthcare settings to address the needs of the elderly population.

In addition, the expansion of the biotechnology industry can be linked to various factors including the introduction of new & innovative products, agreements, acquisitions, technological advancements, and growing adoption across different applications. In May 2023, NeoDx Biotech Labs, an Indian startup, launched 7 real-time PCR-based kits to diagnose infectious diseases, such as Hepatitis C, Hepatitis B, and HIV, at various hospitals and diagnostic centers. Similarly, in January 2023, Bio-Rad announced the launch of a real-time PCR system, CFX Opus Deepwell Dx, which is FDA-approved for IVD testing. Thus, these technological launches are projected to impel the market growth over the period. In addition, companies are launching new products to facilitate better and more advanced sequencing technology.

For instance, in April 2023, Biomodal, formerly known as Cambridge Epigenetix, announced the launch of the duet multiomics solution. This new multiomics sequencing technology is projected to highlight the synergistic potential of genetic and epigenetic insights extracted from a single low-volume sample. Moreover, the solution is one of the first single-base-resolution sequencing technologies, which enables simultaneous, phased reading of both genetic and epigenetic details from a single sample. This increases applications of the technology in unified workflows alongside any sequencing platforms. The increasing adoption of technological advancements in sequencing techniques is anticipated to impel market growth.

Biotechnology Instruments Market Report Highlights:

  • Based on product, the analytical instruments segment dominated the market in 2022 with a share of 61.92%
  • The growing demand for advanced drug development, biomarker discovery, and quality control across pharmaceuticals is anticipated to fuel the segment growth over the forecast period
  • Based on end-use, the pharmaceutical & biotechnological companies segment held the largest market share of 38.10% in 2022
  • This can be attributed to the increased number of drug therapies for various diseases, such as cancer, vaccine developments, and designing diagnostic tools for disease monitoring & detection
  • In 2022, North America dominated the market with a share of 43.95% owing to the presence of major players and robust healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. End-use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends And Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Increasing Demand For Analytical Instruments
    • 3.3.2. Growing Prevalence Of Target Diseases And Rising Geriatric Population
    • 3.3.3. Technological Advancements In Research-Use Instruments
  • 3.4. Market Restraint Analysis
    • 3.4.1. Higher Cost Of Devices
    • 3.4.2. Shortage Of Skilled Professionals
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Biotechnology Instruments Market: Product Movement Analysis
  • 4.2. Analytical Instruments
    • 4.2.1. Analytical Instruments Market, 2018 - 2030 (USD Million)
    • 4.2.2. Polymerase Chain Reaction
      • 4.2.2.1. Polymerase Chain Reaction, 2018 - 2030 (USD Million)
    • 4.2.3. Spectroscopy
      • 4.2.3.1. Spectroscopy, 2018 - 2030 (USD Million)
    • 4.2.4. Microscopy
      • 4.2.4.1. Microscopy, 2018 - 2030 (USD Million)
    • 4.2.5. Chromatography
      • 4.2.5.1. Chromatography, 2018 - 2030 (USD Million)
    • 4.2.6. Flow Cytometry
      • 4.2.6.1. Flow Cytometry, 2018 - 2030 (USD Million)
    • 4.2.7. Sequencing
      • 4.2.7.1. Sequencing, 2018 - 2030 (USD Million)
    • 4.2.8. Microarray
      • 4.2.8.1. Microarray, 2018 - 2030 (USD Million)
    • 4.2.9. Others
      • 4.2.9.1. Others, 2018 - 2030 (USD Million)
  • 4.3. Cell Culture Instruments
    • 4.3.1. Cell Culture Instruments Market, 2018 - 2030 (USD Million)
    • 4.3.2. Culture Systems
      • 4.3.2.1. Culture Systems Market, 2018 - 2030 (USD Million)
    • 4.3.3. Incubators
      • 4.3.3.1. Incubators Market, 2018 - 2030 (USD Million)
    • 4.3.4. Cryostorage Equipment
      • 4.3.4.1. Cryostorage Equipment Market, 2018 - 2030 (USD Million)
    • 4.3.5. Biosafety Equipment
      • 4.3.5.1. Biosafety Equipment Market, 2018 - 2030 (USD Million)
    • 4.3.6. Pipetting Instruments
      • 4.3.6.1. Pipetting Instruments Market, 2018 - 2030 (USD Million)
  • 4.4. Cell Separation Instruments
    • 4.4.1. Cell Separation Instruments Market, 2018 - 2030 (USD Million)
    • 4.4.2. Centrifuge
      • 4.4.2.1. Centrifuge Market, 2018 - 2030 (USD Million)
    • 4.4.3. Filtration Systems
      • 4.4.3.1. Filtration Systems Market, 2018 - 2030 (USD Million)
    • 4.4.4. Magnetic-activated Cell Separator Systems
      • 4.4.4.1. Magnetic-activated Cell Separator Systems Market, 2018 - 2030 (USD Million)
  • 4.5. Immunoassay Instruments
    • 4.5.1. Immunoassay Instruments Market, 2018 - 2030 (USD Million)
  • 4.6. Clinical Chemistry Analyzers
    • 4.6.1. Clinical Chemistry Analyzers Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End-use Business Analysis

  • 5.1. Biotechnology Instruments Market: End-use Movement Analysis
  • 5.2. Pharmaceutical & Biotechnology Companies
    • 5.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 5.3. Hospitals & Diagnostic Laboratories
    • 5.3.1. Hospitals & Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
  • 5.4. Academic & Research Institutes
    • 5.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.2.2.2. Key Country Dynamics
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. Target Disease Prevalence
      • 6.2.2.5. Regulatory Framework
    • 6.2.3. Canada
      • 6.2.3.1. Canada Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.2.3.2. Key Country Dynamics
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Target Disease Prevalence
      • 6.2.3.5. Regulatory Framework
  • 6.3. Europe
    • 6.3.1. Europe Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. Target Disease Prevalence
      • 6.3.2.5. Regulatory Framework
    • 6.3.3. Germany
      • 6.3.3.1. Germany Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Target Disease Prevalence
      • 6.3.3.5. Regulatory Framework
    • 6.3.4. Spain
      • 6.3.4.1. Spain Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.4.2. Key Country Dynamics
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. Target Disease Prevalence
      • 6.3.4.5. Regulatory Framework
    • 6.3.5. France
      • 6.3.5.1. France Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.5.2. Key Country Dynamics
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Target Disease Prevalence
      • 6.3.5.5. Regulatory Framework
    • 6.3.6. Italy
      • 6.3.6.1. Italy Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.6.2. Key Country Dynamics
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Target Disease Prevalence
      • 6.3.6.5. Regulatory Framework
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.7.2. Key Country Dynamics
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Target Disease Prevalence
      • 6.3.7.5. Regulatory Framework
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.8.2. Key Country Dynamics
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Target Disease Prevalence
      • 6.3.8.5. Regulatory Framework
    • 6.3.9. Norway
      • 6.3.9.1. Norway Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.3.9.2. Key Country Dynamics
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Target Disease Prevalence
      • 6.3.9.5. Regulatory Framework
  • 6.4. Asia Pacific
    • 6.4.1. Asia-Pacific Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Target Disease Prevalence
      • 6.4.2.5. Regulatory Framework
    • 6.4.3. China
      • 6.4.3.1. China Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Target Disease Prevalence
      • 6.4.3.5. Regulatory Framework
    • 6.4.4. India
      • 6.4.4.1. India Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Target Disease Prevalence
      • 6.4.4.5. Regulatory Framework
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Target Disease Prevalence
      • 6.4.5.5. Regulatory Framework
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Target Disease Prevalence
      • 6.4.6.5. Regulatory Framework
    • 6.4.7. Australia
      • 6.4.7.1. Australia Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Target Disease Prevalence
      • 6.4.7.5. Regulatory Framework
  • 6.5. Latin America
    • 6.5.1. Latin America Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Target Disease Prevalence
      • 6.5.2.5. Regulatory Framework
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Target Disease Prevalence
      • 6.5.3.5. Regulatory Framework
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Target Disease Prevalence
      • 6.5.4.5. Regulatory Framework
  • 6.6. MEA
    • 6.6.1. MEA Biotechnology Instruments Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Target Disease Prevalence
      • 6.6.2.5. Regulatory Framework
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Target Disease Prevalence
      • 6.6.3.5. Regulatory Framework
    • 6.6.4. UAE
      • 6.6.4.1. UAE Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Target Disease Prevalence
      • 6.6.4.5. Regulatory Framework
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Biotechnology Instruments Market, 2018 - 2030 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Target Disease Prevalence
      • 6.6.5.5. Regulatory Framework

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Thermo Fisher Scientific, Inc.
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Waters Corp.
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Shimadzu Corp.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Danaher
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Agilent Technologies, Inc.
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Bruker Corp.
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. PerkinElmer, Inc.
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Mettler Toledo
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Zeiss Group
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Bio-Rad Laboratories, Inc.
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Illumina, Inc.
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. Eppendorf SE
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. F. Hoffmann-La Roche AG
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic Initiatives
    • 7.4.14. Sartorius AG
      • 7.4.14.1. Company Overview
      • 7.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic Initiatives
    • 7.4.15. Avantor, Inc.
      • 7.4.15.1. Company Overview
      • 7.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Strategic Initiatives